Jsc Froceth

We are the first and only biotechnology company in Lithuania manufacturing advanced therapy medicinal products (ATMPs) individually for each patient. We develop our products using patients’ own tissues and cells in the manufacturing process, and by addressing the specific needs of each person. All our processes are carried out using the most advanced technologies for somatic cell therapy. We started our business in 2014, after combining the knowledge and long-standing experience of qualified biomedical doctors, molecular biologists and biotechnologists, and establishing an adipose tissue bank. In 2015 we established an ATMP manufacturing site in Vilnius. We have established an adipose tissue bank that is one of its kind in Lithuania, for processing, storage and distribution of stromal vascular fraction cells from adipose tissue. It is also the countrys‘ only tissue bank that carries out activities in premises equipped in accordance with Good Manufacturing Practice requirements. Our patented technology of extracted cells from adipose tissue has huge regenerative potential and can restore functions of the damaged tissues. These cells can be used even 20 years after their preparation. We continually keep investing in research related to the production and development of new medicinal products for use in advanced therapies, with the aim to expand the field of personalized therapy in Lithuania. The results of all the scientific research carried out by our scientists are officially published in peer-reviewed journals, and we vigorously participate in projects in collaboration with domestic and foreign biotechnology companies, tissue banks, universities and other scientific institutions.